Medicine:Salivary gland–like carcinoma of the lung
| Salivary gland–like carcinoma of the lung | |
|---|---|
| Specialty | Oncology |
Salivary gland–like carcinomas of the lung generally refers a class of rare cancers that arise from the uncontrolled cell division (mitosis) of mutated cancer stem cells in lung tissue. They take their name partly from the appearance of their abnormal cells, whose structure and features closely resemble those of cancers that form in the major salivary glands (parotid glands, submandibular glands and sublingual glands) of the head and neck.[1] Carcinoma is a term for malignant neoplasms derived from cells of epithelial lineage, and/or that exhibit cytological or tissue architectural features characteristically found in epithelial cells.[2][1]
Types
This class of primary lung cancers contains several histological variants, including mucoepidermoid carcinoma of the lung, adenoid cystic carcinoma of the lung, epithelial-myoepithelial carcinoma of the lung, and other (even more rare) variants.[1]
Diagnosis
Classification
Lung cancer is a large and exceptionally heterogeneous family of malignancies.[3] Over 50 different histological variants are explicitly recognized within the 2004 revision of the World Health Organization (WHO) typing system ("WHO-2004"), currently the most widely used lung cancer classification scheme.[1] Many of these entities are rare, recently described, and poorly understood.[4] However, since different forms of malignant tumors generally exhibit diverse genetic, biological, and clinical properties — including response to treatment — accurate classification of lung cancer cases are critical to assuring that patients with lung cancer receive optimum management.[5][6]
Under WHO-2004, lung carcinomas are divided into 8 major taxa:[1]
- Squamous cell carcinoma
- Small cell carcinoma
- Adenocarcinoma
- Large cell carcinoma
- Adenosquamous carcinoma
- Sarcomatoid carcinoma
- Carcinoid tumor
- Salivary gland-like carcinoma
Treatment
Treatment options may include surgery, radiation, and chemotherapy. Icotinib has been temporarily effective at treating salivary gland-like carcinoma of the lung but loses efficiency after three months. [7]
References
- ↑ 1.0 1.1 1.2 1.3 1.4 Travis, William D; Brambilla, Elisabeth; Muller-Hermelink, H Konrad et al., eds (2004). Pathology and Genetics of Tumours of the Lung, Pleura, Thymus and Heart. World Health Organization Classification of Tumours. Lyon: IARC Press. ISBN 92-832-2418-3. http://www.iarc.fr/en/publications/pdfs-online/pat-gen/bb10/bb10-cover.pdf. Retrieved 27 March 2010.
- ↑ "Lung cancer". Cancer 75 (1 Suppl): 191–202. January 1995. doi:10.1002/1097-0142(19950101)75:1+<191::AID-CNCR2820751307>3.0.CO;2-Y. PMID 8000996.
- ↑ "Lung cancer heterogeneity: a blinded and randomized study of 100 consecutive cases". Hum. Pathol. 16 (6): 569–79. June 1985. doi:10.1016/S0046-8177(85)80106-4. PMID 2987102.
- ↑ "The new World Health Organization classification of lung tumours". Eur. Respir. J. 18 (6): 1059–68. December 2001. doi:10.1183/09031936.01.00275301. PMID 11829087.
- ↑ Rossi G, Marchioni A, Sartori1 G, Longo L, Piccinini S, Cavazza A (2007). "Histotype in non-small cell lung cancer therapy and staging: The emerging role of an old and underrated factor". Curr Respir Med Rev 3: 69–77. doi:10.2174/157339807779941820.
- ↑ Vincent MD (August 2009). "Optimizing the management of advanced non-small-cell lung cancer: a personal view". Curr Oncol 16 (4): 9–21. doi:10.3747/co.v16i4.465. PMID 19672420.
- ↑ Kawakado, Keita; Tamura, Tomoki; Nakanishi, Masamoto; Makimoto, Go; Sato, Yumiko; Kuyama, Shoichi (2021-08-08). "Carboplatin, pemetrexed, and pembrolizumab was effective for primary salivary gland‐type lung adenocarcinoma diagnosed due to esophageal stricture: A case report". Thoracic Cancer (Wiley) 12 (18): 2513–2516. doi:10.1111/1759-7714.14100. ISSN 1759-7706. PMID 34369074.
External links
- Lung Cancer Home Page. The National Cancer Institute site containing further reading and resources about lung cancer.
- World Health Organization Histological Classification of Lung and Pleural Tumours. 4th Edition (2004).
 |  |
